New Zealand’s Commerce Commission has approved Kimberly-Clark’s acquisition of Kenvue. Clearance requires the business to divest Kenvue’s feminine hygiene operations across New Zealand and Australia.
This divestment covers regional rights to brands including Carefree and Stayfree. The condition aims to prevent excessive market concentration on supermarket shelves.
Conditions for Clearance Across Australasia
Kimberly-Clark is acquiring Kenvue, the consumer health spin-off from Johnson & Johnson, in a global takeover. Under an undertaking given to the regulator, Kimberly-Clark must sell the entire Kenvue feminine care unit in both countries to an approved independent buyer.
Commerce Commission deputy chair Anne Callinan said the remedy protects competition across personal care aisles, where both suppliers held overlapping product lines.
Supermarket Consolidation and Buyer Timelines
Australasian retailers face tightening supplier networks as multinational consumer goods groups consolidate personal care portfolios. Selling Carefree and Stayfree keeps an independent supplier in play against Kimberly-Clark’s Kotex and U by Kotex lines.
Attention now turns to the asset sale. Kimberly-Clark must secure a commission-approved buyer within a confidential, binding timeframe to finalize the broader merger clearance.
Leave a Reply